Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 24, 2024 10:53 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Apr 24, 2024 10:50 ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Checkpoint Therapeutics, Inc. (“Checkpoint” or “the Company”) (NASDAQ: CKPT) for for violations of §§10(b) and 20(a) of the...
Apr 24, 2024 10:48 ET
Challenged Athletes Foundation and Össur Amplify Support for Athletes with Limb Loss and Limb Differences with 115 New Grants and Mobility Clinics Offered Nationwide
The Challenged Athletes Foundation (CAF) and Össur, a global leader in prosthetics, are proud to announce they have granted 115 new prosthetic sports feet and knees to people of all ages with limb loss and limb differences as part of CAF's landmark...
Apr 24, 2024 10:47 ET
Execution of Definitive Agreement to Acquire up to 67% of Giraffe Energy – Expansion of Orange Basin Platform in Namibia & Creation of Community Trust
Sintana Energy Inc. (TSX-V: SEI, OTCQB: SEUSF) (“Sintana” or the “Company”) is pleased to announce that it has entered into a definitive agreement dated effective April 24th, 2024 with Crown Energy (Pty) Ltd. (“Crown Energy”), a private Namibian...
Apr 24, 2024 10:47 ET
FFW Corporation Announces Earnings for the Quarter and Year to Date Ended March 31, 2024
FFW Corporation (the “Corporation”) (OTC PINK: FFWC) (4/23/2024 Close: $34.65), parent corporation of Crossroads Bank (the “Bank”), announced earnings for the quarter and year to date ended March 31, 2024. For the three months ended March 31,...
Apr 24, 2024 10:43 ET
NMDP to Present New Stem Cell Transplantation Data at the 2024 American Society of Clinical Oncology Annual Meeting
NMDP℠, a global nonprofit leader in cell therapy, and CIBMTR® (Center for International Blood and Marrow Transplant Research®) will present new data on hematopoietic cell transplantation (HCT) treatment effects in patients with hematological...
Apr 24, 2024 10:42 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Primerica, Inc. - PRI
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. (“Primerica” or the “Company”) (NYSE: PRI).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.    The...
Apr 24, 2024 10:40 ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Luna Innovations Incorporated with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Luna Innovations Incorporated (“Luna” or “the Company”) (NASDAQ: LUNA) for for violations of §§10(b) and 20(a) of the Securities...
Apr 24, 2024 10:38 ET
Diffblue Launches GitHub Actions Integration for AI-Powered Autonomous Unit Testing
Diffblue, the leading provider of AI-powered unit testing solutions, today announced the launch of Diffblue Cover Pipeline for GitHub Actions, an essential CI pipeline integration capability that enables unit test generation at scale and unit test...
Apr 24, 2024 10:32 ET
Xtract One Closes $7.2M Public Offering and $1.4M Investment by Strategic Partner
Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) announces that it has closed its previously announced public offering (the “Offering”) conducted by Eight Capital, as lead agent and sole bookrunner,...
Apr 24, 2024 10:31 ET
Class 1 Nickel Updates Resource Estimate on High-Grade Alexo South Nickel Sulphide Deposit – Significant Increases in Indicated and Inferred Resources Over the 2020 Estimate
Class 1 Nickel and Technologies Ltd. (CSE: NICO | OTCQB: NICLF) ("Class 1 Nickel" or the "Company") is pleased to announce an updated mineral resource estimate (“MRE”) for the Alexo South Nickel Deposit (“A-S Deposit”) (Table 1). The A-S Deposit,...
Apr 24, 2024 10:30 ET
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) S
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that a late-breaking abstract with preliminary...
Apr 24, 2024 10:30 ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. (“bluebird” or “the Company”) (NASDAQ: BLUE) for violations of §§10(b) and 20(a) of the Securities Exchange...
Apr 24, 2024 10:20 ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Evolv Technologies Holdings, Inc. with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. (“Evolv” or “the Company”) (NASDAQ: EVLV) for violations of...
Apr 24, 2024 10:18 ET
Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and...
Apr 24, 2024 10:18 ET
Granite Creek Announces Investment in The District Communications Group (DCG)
Granite Creek Capital Partners, in partnership with Boathouse Capital, today announced an investment in The District Communications Group (DCG), a full-service communications firm providing comprehensive market research and strategic communications...
Apr 24, 2024 10:11 ET
Fulcrum GT Renews Its Commitment to Els for Autism Foundation
Fulcrum GT, provider of the leading digital business platform for legal and professional services firms from new business inception through billing and finance operations to HCM and analytics, is proud to announce its continued commitment to...
Apr 24, 2024 10:10 ET
Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
Future Business Leaders of America, Inc. (FBLA), the nation’s largest career and technical student organization focused solely on business, invites business and technology professionals to build their workforce pipeline by volunteering during its...
Apr 24, 2024 10:09 ET
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advance
Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced that clinical data from its Phase 1 trial of CLN-619 in patients with advanced solid tumors will be presented...
Apr 24, 2024 10:08 ET
Blue Island Homes Chosen as Exclusive Listing Brokers for Ocean Watch at Harbor Pointe: A Premier Gated Waterfront Living Experience in Freeport, New York
Blue Island Homes proudly announces its latest venture as the exclusive listing brokers for the final phase at Ocean Watch at Harbor Pointe, a luxurious waterfront development of 61 townhomes, located in Freeport, New York. This esteemed assignment...